BAT’s US Bio-tech arm, Kentucky BioProcessing (KBP) today announced plans to commence a Phase I first-time-in-human study of its COVID-19 vaccine candidate following approval of its Investigational New Drug application by the U.S. Food and Drug Administration (FDA). Enrollment for the study is expected to begin shortly. Full press release, intended for use by the media only, available … Continued
For the 19th year in a row, British American Tobacco (BAT) has been named in the Dow Jones Sustainability Index – the only tobacco company to be included on the prestigious list. This announcement is a further demonstration of BAT’s continued commitment to its purpose to build A Better Tomorrow by reducing the health impact of its … Continued
More than 85% of employees call Reynolds a Great Place to Work WINSTON-SALEM, N.C., Sept. 10, 2020– For the fourth consecutive year, Reynolds American Inc. (Reynolds) has been certified as a Great Place to Work® and has again been named by FORTUNE Magazine as one of its 2020 Best Workplaces. With more than 85% of employees stating that the … Continued
Grouped Alto applications are final FDA submission for deemed products, representing both Vuse and VELO portfolios Reynolds completes 2020 deemed product PMTA submissions for one of the broadest portfolios in the industry Reynolds has provided the FDA with more than 530,000 pages of scientific data for review as part of all PMTA applications submitted More … Continued
VELO pouch is second group of PMTAs for VELO products, and completes current VELO brand PMTA submissions WINSTON-SALEM, NC. September 1, 2020 – Reynolds American Inc. (“Reynolds”) announces today the submission of a group of Premarket Tobacco Product Applications (“PMTAs”) to the U.S. Food and Drug Administration (“FDA”) seeking orders authorizing the marketing of VELO pouches. … Continued
FDA applications are a first for VELO’s dissolvable nicotine lozenges WINSTON-SALEM, N.C. – August 24, 2020 – Reynolds American Inc. (“Reynolds”) announces today the submission of a group of Premarket Tobacco Product Applications (“PMTAs”) to the U.S. Food and Drug Administration (“FDA”) seeking orders authorizing the marketing of VELO dissolvable nicotine lozenges. A grant of these … Continued
Reynolds stands against racism and discrimination in all forms, and we condemn all acts of hate against African Americans and other groups. Our recruitment of a diverse workforce in order to create a culture of inclusion where employees are treated equally will continue to be one of our top priorities. We have a long way … Continued
Vuse Vibe and Vuse Ciro join Reynolds’ Prior Vuse Solo Submission to FDA WINSTON-SALEM, N.C. – April 15, 2020 – Reynolds American (“Reynolds”) announced today that it has submitted two new Premarket Tobacco Product Applications (“PMTAs”) to the U.S. Food and Drug Administration (“FDA”). Reynolds is seeking marketing orders for their Vuse Vibe and Vuse Ciro … Continued
Potential vaccine in development for COVID-19 using new, fast-growing tobacco plant technology – pre-clinical testing under way Tobacco plants offer the potential for faster and safer vaccine development compared to conventional methods Potential to manufacture 1-3 million doses of vaccine per week April 1, 2020: BAT’s US bio-tech subsidiary, Kentucky BioProcessing (KBP), is developing a potential vaccine for … Continued
Reynolds American Inc. Group earns top marks in 2020 Corporate Equality Index, designated a “Best Place to Work for LGBTQ Equality” Comprehensive parental leave, employee resource groups and CEO pledge to promote diversity and inclusion among reasons RAI Group scored 100% on Human Rights Campaign Foundation’s annual assessment WINSTON-SALEM, N.C. – Jan. 22, 2020 – The … Continued
